MAGNET Trial of the Year 2024- The KADS Trial

MAGNET Trial of the Year 2024

The KADS Trial Sets a New Standard in Depression Treatment Research

The 2024 MAGNET Trial of the Year has been awarded to The KADS Trial, a groundbreaking study that has redefined the treatment landscape for patients with treatment-resistant depression (TRD).

This landmark achievement, led by Professor Colleen Loo of UNSW and the Black Dog Institute, marks a significant breakthrough in mental health care by providing robust evidence for the efficacy and safety of generic ketamine as a treatment for severe depression.

Read the fill article here: MAGNET Article- MAGNET Trial of the Year 2024